Detalhe da pesquisa
1.
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 2021 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348236
2.
Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma.
Mol Cell
; 34(1): 115-31, 2009 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19362540
3.
Dysfunctional states of unconventional T-cell subsets in cancer.
J Leukoc Biol
; 115(1): 36-46, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837379
4.
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.
Cell Death Dis
; 15(3): 198, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459020
5.
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.
Clin Cancer Res
; 29(7): 1209-1219, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378549
6.
Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.
Nat Commun
; 14(1): 3214, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270644
7.
Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma.
JAMA Netw Open
; 5(12): e2246400, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512357
8.
BRAF Modulates Lipid Use and Accumulation.
Cancers (Basel)
; 14(9)2022 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565240
9.
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics.
J Invest Dermatol
; 142(7): 1912-1922.e7, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942200
10.
Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients.
Clin Transl Immunology
; 11(1): e1367, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028137
11.
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.
Cancer Discov
; 12(12): 2856-2879, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098958
12.
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
Pharmaceuticals (Basel)
; 14(8)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451846
13.
Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
Melanoma Res
; 30(6): 562-573, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156595
14.
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes.
Immunohorizons
; 4(2): 82-92, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071067
15.
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
Cell Death Dis
; 11(6): 443, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513939
16.
BRAF fusions identified in melanomas have variable treatment responses and phenotypes.
Oncogene
; 38(8): 1296-1308, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254212
17.
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.
Front Oncol
; 9: 1223, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31781510
18.
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.
Cell Death Dis
; 9(9): 907, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185782
19.
ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.
Mol Cancer Ther
; 17(1): 222-231, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054983
20.
Acral Lentiginous Melanoma Harboring a ROS1 Gene Fusion With Clinical Response to Entrectinib.
JCO Precis Oncol
; 1: 1-7, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172482